VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 703 filers reported holding VANECK VECTORS ETF TR in Q2 2022. The put-call ratio across all filers is 0.58 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $268,252 | -73.4% | 8,292 | -77.5% | 0.01% | -77.1% |
| Q2 2022 | $1,008,000 | +227.3% | 36,817 | +199.0% | 0.05% | +242.9% |
| Q3 2021 | $308,000 | -59.0% | 12,315 | -44.4% | 0.01% | -62.2% |
| Q2 2021 | $752,000 | +113.0% | 22,139 | +110.9% | 0.04% | +85.0% |
| Q1 2021 | $353,000 | -42.8% | 10,499 | -38.7% | 0.02% | -55.6% |
| Q4 2020 | $617,000 | -35.3% | 17,117 | -29.7% | 0.04% | -47.1% |
| Q3 2020 | $954,000 | +225.6% | 24,358 | +205.4% | 0.08% | +193.1% |
| Q2 2020 | $293,000 | +13.6% | 7,976 | -9.5% | 0.03% | -9.4% |
| Q4 2019 | $258,000 | +8.9% | 8,813 | -0.8% | 0.03% | -13.5% |
| Q3 2019 | $237,000 | -29.9% | 8,883 | -32.8% | 0.04% | -35.1% |
| Q2 2019 | $338,000 | -54.4% | 13,221 | -60.0% | 0.06% | -49.6% |
| Q1 2019 | $741,000 | +8133.3% | 33,068 | +187.5% | 0.11% | +3666.7% |
| Q4 2017 | $9,000 | – | 11,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Hollow Brook Wealth Management LLC | 711,589 | $25,631,000 | 15.27% |
| Sloane Robinson LLP | 450,000 | $16,209,000 | 15.04% |
| New Harbor Financial Group, LLC | 1,103,389 | $39,744,000 | 14.30% |
| Brown University | 541,096 | $19,490,000 | 14.10% |
| Grand Central Investment Group | 426,777 | $15,373,000 | 13.75% |
| New Harbor Financial Group, LLC | 1,055,400 | $38,015,000 | 13.68% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $26,601,000 | 11.26% |
| Brevan Howard Capital Management LP | 1,420,000 | $51,148,000 | 10.26% |
| Nokomis Capital, L.L.C. | 603,528 | $21,739,000 | 9.52% |
| tru Independence LLC | 139,120 | $5,011,102,000 | 9.10% |